Dexmedetomidine suppresses the progression of esophageal cancer via miR-143-3p/epidermal growth factor receptor pathway substrate 8 axis

Esophageal cancer is one of the fatal cancers around the world. Dexmedetomidine (DEX) is widely used during anesthesia of esophageal cancer surgery. Nevertheless, the role of DEX in the progression of esophageal cancer remains barely known. The proliferation, apoptosis and metastasis of esophageal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Peisen, He, Hefan, Bai, Yuyan, Liu, Weifeng, Huang, Lirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Preclinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365679/
https://www.ncbi.nlm.nih.gov/pubmed/32701250
http://dx.doi.org/10.1097/CAD.0000000000000934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365679/
https://www.ncbi.nlm.nih.gov/pubmed/32701250
http://dx.doi.org/10.1097/CAD.0000000000000934

Ejemplares similares